
Biotwin builds virtual human twins to enable early disease detection, predict treatment responses, and support preventive care. It uses AI to model biometric and biomarker data — including metabolites, lipids, and proteins — to generate personalized digital twins for virtual testing of therapies and risk prediction. Data is collected via an at-home biomarker kit and processed by predictive models and clinician-facing decision-support tools. The company is a precision medicine platform serving healthcare professionals and organizations to improve diagnostic accuracy and personalize care at scale.

Biotwin builds virtual human twins to enable early disease detection, predict treatment responses, and support preventive care. It uses AI to model biometric and biomarker data — including metabolites, lipids, and proteins — to generate personalized digital twins for virtual testing of therapies and risk prediction. Data is collected via an at-home biomarker kit and processed by predictive models and clinician-facing decision-support tools. The company is a precision medicine platform serving healthcare professionals and organizations to improve diagnostic accuracy and personalize care at scale.